Christian Gröndahl
Chief Executive Officer at SNIPR Biome ApS
Christian Gröndahl active positions
Companies | Position | Start | End |
---|---|---|---|
Vitrolife A/S
Vitrolife A/S Industrial MachineryProducer Manufacturing Part of Vitrolife AB, Vitrolife A/S is a Danish company that manufactures laboratory equipment and customizes software. The company is based in Aarhus, Denmark. Kjær Andreasen has been the CEO of the company since 2014. Vitrolife was acquired by Vitrolife AB on November 26, 2014 for $84.11 million. | Director/Board Member | - | - |
SNIPR Biome ApS
SNIPR Biome ApS Pharmaceuticals: MajorHealth Technology SNIPR Biome ApS develops bacterial composition to provide treatment for diabetes to cancer. The company was founded by Christian Grøndal and is headquartered in Kongens Lyngby, Denmark. | Chief Executive Officer | 2017-08-10 | - |
Founder | 2017-08-10 | - | |
Tubulis GmbH
Tubulis GmbH Pharmaceuticals: MajorHealth Technology Tubulis GmbH engages in biotechnology company. The firm develops matched protein-drug conjugates by combining proprietary novel technologies with disease-specific biology. The company was founded by Dominik Schumacher and Jonas Helma-Smets and is headquartered in Munich, Germany. | Chairman | 2021-05-10 | - |
Independent Dir/Board Member | 2021-05-10 | - |
Career history of Christian Gröndahl
Former positions of Christian Gröndahl
Companies | Position | Start | End |
---|---|---|---|
NOVO NORDISK A/S | Corporate Officer/Principal | 2009-12-31 | 2009-12-31 |
Freeline Therapeutics Ltd.
Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | Director/Board Member | - | - |
Setisila Oy
Setisila Oy Information Technology ServicesTechnology Services Setisila Oy develops and publishes software solutions for the processing of digital information. The firm specializes in the implementation of web applications, content management, and information systems. Its services include internet; intranet; extranet; needs assessment; concept and consulting services; project management; hosting services; maintenance contract; and training . The company was founded in 1998 and is headquartered in Helsinki, Finland. | Chairman | - | - |
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Director/Board Member | 2013-09-15 | - |
Chief Executive Officer | 2013-09-15 | - | |
Kongeriget Danmarks Hesteforsikring G/S | Director/Board Member | - | - |
ZEALAND PHARMA A/S | Chief Tech/Sci/R&D Officer | 2010-04-05 | - |
Training of Christian Gröndahl
University of Copenhagen | Doctorate Degree |
International Institute for Management Development | Masters Business Admin |
Statistics
International
Denmark | 7 |
United Kingdom | 3 |
Finland | 2 |
Operational
Director/Board Member | 4 |
Chief Executive Officer | 2 |
Chairman | 2 |
Sectoral
Health Technology | 7 |
Consumer Services | 3 |
Technology Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
NOVO NORDISK A/S | Health Technology |
ZEALAND PHARMA A/S | Health Technology |
Private companies | 7 |
---|---|
Setisila Oy
Setisila Oy Information Technology ServicesTechnology Services Setisila Oy develops and publishes software solutions for the processing of digital information. The firm specializes in the implementation of web applications, content management, and information systems. Its services include internet; intranet; extranet; needs assessment; concept and consulting services; project management; hosting services; maintenance contract; and training . The company was founded in 1998 and is headquartered in Helsinki, Finland. | Technology Services |
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Vitrolife A/S
Vitrolife A/S Industrial MachineryProducer Manufacturing Part of Vitrolife AB, Vitrolife A/S is a Danish company that manufactures laboratory equipment and customizes software. The company is based in Aarhus, Denmark. Kjær Andreasen has been the CEO of the company since 2014. Vitrolife was acquired by Vitrolife AB on November 26, 2014 for $84.11 million. | Producer Manufacturing |
Kongeriget Danmarks Hesteforsikring G/S | |
Freeline Therapeutics Ltd.
Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | Health Technology |
SNIPR Biome ApS
SNIPR Biome ApS Pharmaceuticals: MajorHealth Technology SNIPR Biome ApS develops bacterial composition to provide treatment for diabetes to cancer. The company was founded by Christian Grøndal and is headquartered in Kongens Lyngby, Denmark. | Health Technology |
Tubulis GmbH
Tubulis GmbH Pharmaceuticals: MajorHealth Technology Tubulis GmbH engages in biotechnology company. The firm develops matched protein-drug conjugates by combining proprietary novel technologies with disease-specific biology. The company was founded by Dominik Schumacher and Jonas Helma-Smets and is headquartered in Munich, Germany. | Health Technology |
- Stock Market
- Insiders
- Christian Gröndahl
- Experience